Renal Artery Obstruction: Clinical Trials

7 trials for Renal Artery Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7
Phase 21Completed 1

Follow Renal Artery Obstruction: new trials by email Literature Review of Renal Artery Obstruction trials Research Report on Renal Artery Obstruction

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Compare Effects of Intensive Versus Conventional Lipid-lowering Therapy in Patients With Severe Atherosclerotic Renal Artery Stenosis Undergoing Stent Placement
Rosuvastatin - Renal Artery Obstruction, Stents
Phase 2 / Phase 3CompletedChinese Academy of Medical Sciences, Fuwai Hospital1502013-06-012018-05-29
Gadobutrol Enhanced MRA of the Renal Arteries
Gadobutrol (Gadovist, BAY86-4875) - Renal Artery Obstruction
Phase 3CompletedBayer3172011-05-012015-08-26
Comparison of Best Medical Treatment Versus Best Medical Treatment Plus Renal Artery Stenting
Dynamic Renal Stent plus Best Medical Treatment, Best Medical Treatment - Renal Artery Stenosis
Phase 3CompletedBiotronik AG862008-04-012015-07-21
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Atacand/HCT, Caduet, GENESISTM Embolic Protection Stent and Angioguard Device (Angioplasty plus stenting) - Atherosclerosis, Cardiovascular Diseases
Phase 3CompletedBaim Institute for Clinical Research9472004-04-012015-10-05
Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries
Gadopentetate dimeglumine (Magnevist) - Renal Artery Stenosis
Phase 3CompletedBayer1162003-12-012014-12-30
A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide
Gadodiamide Injection - Renal Artery Stenosis
Phase 3CompletedGE Healthcare3952003-09-012019-04-25
Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis
Renal artery stent - Renal Artery Obstruction, Kidney Failure
Phase 3CompletedUMC Utrecht1402000-06-012006-04-27

Narrower conditions

Atherosclerosis (2)  ·  Bites and Stings (1)  ·  Cardiovascular Diseases (1)  ·  Hypertension (1)  ·  Hypertension, Renovascular (1)  ·  Renal Insufficiency (1)

Broader conditions

Arterial Occlusive Diseases (7)  ·  Female Urogenital Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (7)  ·  Kidney Diseases (7)  ·  Male Urogenital Diseases (7)  ·  Urogenital Diseases (7)  ·  Urologic Diseases (7)  ·  Vascular Diseases (7)  ·  Cardiovascular Diseases (6)  ·  Arteriosclerosis (2)  ·  Chemically-Induced Disorders (1)  ·  Hypertension (1)  ·  Hypertension, Renal (1)  ·  Poisoning (1)  ·  Wounds and Injuries (1)

Interventions

Angioplasty (1)  ·  Gadolinium DTPA (1)  ·  Rosuvastatin Calcium (1)  ·  Stents (1)  ·  amlodipine, atorvastatin drug combination (1)  ·  gadobutrol (1)  ·  gadodiamide (1)

Sponsors

Bayer (2)  ·  Baim Institute for Clinical Research (1)  ·  Biotronik AG (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  GE Healthcare (1)  ·  UMC Utrecht (1)

Countries

Germany (3)  ·  United States (2)  ·  Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  China (1)  ·  Colombia (1)  ·  Czechia (1)  ·  France (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Alan Matsumoto, MD (1)  ·  Christopher J. Cooper, MD (1)  ·  David Cohen, MD (1)  ·  Donald Cutlip, MD (1)  ·  Jaap J. Beutler, MD.PhD (1)  ·  Lance D Dworkin, MD (1)  ·  Michael Karl, PhD (1)  ·  Michael Steffes, MD (1)  ·  Scott D Solomon, MD (1)  ·  Thomas Zeller, PD Dr. med (1)  ·  Timothy P Murphy, MD (1)  ·  Xiongjing Jiang, MD (1)

Results publications

PMID 19414832, PMID 19635148, PMID 24245566, PMID 24245567, PMID 24325931, PMID 24903387, PMID 26653621, PMID 27647847, PMID 28807045, PMID 30962703, PMID 34183258, PMID 39402005

NIH funding

U01HL071556 (1)